Roche hit by failure of trial for cancer drug Kadcyla
December 19, 2014 at 10:16 AM EST
Roche Holding says a late-stage study of the breast-cancer drug Kadcyla failed to yield superior results to an existing treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.